Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

A survey of pharmaceutical company representative interactions with doctors in Libya.

Alssageer MA, Kowalski SR.

Libyan J Med. 2012;7. doi: 10.3402/ljm.v7i0.18556. Epub 2012 Sep 18.

2.

What do Libyan doctors perceive as the benefits, ethical issues and influences of their interactions with pharmaceutical company representatives?

Alssageer MA, Kowalski SR.

Pan Afr Med J. 2013 Apr 6;14:132. doi: 10.11604/pamj.2013.14.132.2598. Print 2013.

3.

Doctors' opinions of information provided by Libyan pharmaceutical company representatives.

Alssageer MA, Kowalski SR.

Libyan J Med. 2012;7. doi: 10.3402/ljm.v7i0.19708. Epub 2012 Nov 28.

5.

A survey of german physicians in private practice about contacts with pharmaceutical sales representatives.

Lieb K, Brandtönies S.

Dtsch Arztebl Int. 2010 Jun;107(22):392-8. doi: 10.3238/arztebl.2010.0392. Epub 2010 Jun 4.

7.

Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia.

McNeill PM, Kerridge IH, Henry DA, Stokes B, Hill SR, Newby D, Macdonald GJ, Day RO, Maguire J, Henderson KM.

Intern Med J. 2006 Sep;36(9):571-8.

PMID:
16911549
8.

2001 survey on primary medical care in Singapore.

Emmanuel SC, Phua HP, Cheong PY.

Singapore Med J. 2004 May;45(5):199-213.

10.

Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.

Edwards D, Ballantyne A.

Intern Med J. 2009 Mar;39(3):191-6. doi: 10.1111/j.1445-5994.2008.01887.x.

PMID:
19383067
11.
12.

Assessment of doctors' knowledge regarding tuberculosis management in Lucknow, India: a public-private sector comparison.

Vandan N, Ali M, Prasad R, Kuroiwa C.

Public Health. 2009 Jul;123(7):484-9. doi: 10.1016/j.puhe.2009.05.004. Epub 2009 Jun 26.

PMID:
19560176
13.

[Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].

Gundermann C, Meier-Hellmann A, Bauer M, Hartmann M.

Dtsch Med Wochenschr. 2010 May;135(3):67-70. doi: 10.1055/s-0029-1244818. Epub 2010 Jan 14. German.

PMID:
20077378
14.

How and why public sector doctors engage in private practice in Portuguese-speaking African countries.

Ferrinho P, Van Lerberghe W, Julien MR, Fresta E, Gomes A, Dias F, Gonçalves A, Bäckström B.

Health Policy Plan. 1998 Sep;13(3):332-8.

15.

Patients' attitudes about gifts to physicians from pharmaceutical companies.

Blake RL Jr, Early EK.

J Am Board Fam Pract. 1995 Nov-Dec;8(6):457-64.

PMID:
8585404
16.

A study on the interactions of doctors with medical representatives of pharmaceutical companies in a Tertiary Care Teaching Hospital of South India.

Gupta SK, Nayak RP, Sivaranjani R.

J Pharm Bioallied Sci. 2016 Jan-Mar;8(1):47-51. doi: 10.4103/0975-7406.171695.

17.

Attitudes of Danish doctors and nurses to palliative and terminal care.

Vejlgaard T, Addington-Hall JM.

Palliat Med. 2005 Mar;19(2):119-27.

PMID:
15810750
18.

Continuing education for general practice and the role of the pharmaceutical industry.

Hayes TM, Allery LA, Harding KG, Owen PA.

Br J Gen Pract. 1990 Dec;40(341):510-2.

19.

Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario.

Sergeant MD, Hodgetts PG, Godwin M, Walker DM, McHenry P.

CMAJ. 1996 Nov 1;155(9):1243-8.

20.

The Libyan doctors' brain drain: an exploratory study.

Benamer HTs, Bredan A, Bakoush O.

BMC Res Notes. 2009 Dec 8;2:242. doi: 10.1186/1756-0500-2-242.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk